Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Refreshes and revitalizes skin
Animal studies show IGF-1 LR3 can cause organ growth and changes in insulin and blood sugar levels
Long-term safety in injectable use is not well characterized in published trials
For obesity treatment, dose escalation protocols starting at lower doses (e.g., 2 mg) and gradually increasing to maintenance doses (e.g., 4 mg, 8 mg, or 12 mg) have been studied Link below for more detailed information: Product Overview: Retatrutide research peptide, a novel multi-agonist peptide with activity across GLP-1, GIP, and glucagon pathways
US$ 27.92
US$ 23.05
US$ 20.02
US$ 29.82
US$ 29.84
US$ 24.84
